Mountain Pacific Partners

Xenocor Inc, based in Salt Lake City, Utah, specializes in designing and developing innovative medical devices, particularly for laparoscopic surgery. The company focuses on single-use, high-definition laparoscopy devices that provide superior imaging quality without the need for a power grid. This design allows for minimally invasive surgical procedures at a lower cost compared to traditional methods. Xenocor's xenoscope medical device enhances the safety and effectiveness of surgeries performed in hospitals, surgery centers, and medical outreach organizations, thereby delivering high value to healthcare providers and patients alike.

1st Source Consulting LLC provides business consulting services. The company offers accounting, funding, management, marketing, manufacturing, human resource and benefits, website support, and legal support services. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

Turner Imaging Systems is a developer of the Smart-C battery-powered mini C-arm. The company develops and markets X-ray imaging systems that give the user the ability to acquire X-ray images wherever and whenever they are needed. The latest product, the SMART-C arm, is a fully-functional mini-C-arm system that is battery operated and hand-transportable, improving the way fluoroscopy is performed. Turner Imaging Systems products expand the reach of X-ray imaging to the under-served and humanitarian efforts around the world.

Layla Wellness is a Canadian company that specializes in the development of an intravaginal fertility monitor ring designed to identify the most fertile days for women. This innovative product tracks cervical fluid, which is crucial for conception, and provides users with advanced notice of their fertile window. By integrating this monitoring ring with a mobile application, Layla Wellness offers a user-friendly solution for women seeking to understand their fertility patterns more effectively.

iVeena Delivery Systems, Inc. is a biopharmaceutical company based in Salt Lake City, Utah, specializing in ophthalmology products. Founded in 2006 by Bala Ambati, the company focuses on developing innovative therapies for various ocular conditions. Its product line includes IVMED-10, IVMED-20, IVMED-80, and IVMED-85, which are aimed at treating post-cataract inflammation and pediatric myopia. Additionally, iVeena is engaged in research and development of novel drug candidates targeting conditions such as macular degeneration, diabetic retinopathy, and glaucoma. The company employs a unique drug delivery platform designed to enhance the ocular bioavailability of medications, facilitating effective treatment for both anterior and posterior segments of the eye. Currently, iVeena has several products in the late pre-clinical and research phases, focusing on advanced therapeutic solutions for ophthalmic diseases.

Navigen Inc. is a pharmaceutical discovery and development company based in Salt Lake City, Utah, founded in 2014. The company specializes in drug development using D-peptides, with a focus on various therapeutic areas, including HIV prevention and treatment, cancer immunotherapy, and autoimmune diseases. Notable products include CPT31 for HIV, a D-peptide targeting SIRPα for cancer treatment, and an anti-TNF D-peptide that offers advantages over existing biologics. Navigen has effectively implemented a strategy of sourcing early-stage technologies from academic institutions, advancing these innovations through pre-Investigational New Drug studies with the support of approximately $40 million in non-dilutive funding from grants and collaborations. The company aims to file IND applications for its key programs within the next year.